Debashree Basu is a senior scientist in the analytical development group at Ultragenyx. Her work focuses on the functional potency assay development of different AAV gene therapy programs. Before joining Ultragenyx, she worked at Homology Medicines, where she worked on developing different gene editing assays. She was a Research Scientist in University of Minnesota and University of Texas. She received her PhD in Biochemistry from Manipal University, India and was a Postdoctoral Fellow in University of Texas Medical Branch.